FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Opuviz (aflibercept-yszy) - May 20, 2024
- Yesafili (aflibercept-jbvf) - May 20, 2024
- Imdelltra (tarlatamab-dlle) - May 16, 2024
- Myhibbin (mycophenolate mofetil) - May 01, 2024
- Beqvez (fidanacogene elaparvovec-dzkt) - April 26, 2024
- Libervant (diazepam) - April 26, 2024
- Xolremdi (mavorixafor) - April 26, 2024
- Hercessi (trastuzumab-strf) - April 25, 2024
- Pivya (pivmecillinam) - April 24, 2024
- Ojemda (tovorafenib) - April 23, 2024
- Anktiva (nogapendekin alfa inbakicept-pmln) - April 22, 2024
- Rezenopy (naloxone hydrochloride) - April 19, 2024
- Lumisight (pegulicianine) - April 17, 2024
- Selarsdi (ustekinumab-aekn) - April 16, 2024
- Xromi (hydroxyurea) - April 04, 2024
- Zevtera (ceftobiprole medocaril) - April 03, 2024
- Risvan (risperidone) - March 29, 2024
- Voydeya (danicopan) - March 29, 2024
- Vafseo (vadadustat) - March 27, 2024
- Winrevair (sotatercept) - March 26, 2024